Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199 | 1.00 | CETP (0.39) | CETPALDH1A1HSD17B10PKM | |
| SCHEMBL2262667 | 1.00 | CETP (0.39) | CETPALDH1A1HSD17B10PKM | |
| Ammonia Solution, Strong SCHEMBL28844128 | 0.95 | CETP (0.37) | CETP | |
| SCHEMBL31548816 | 0.95 | CETP (0.37) | CETP | |
| SCHEMBL27683107 | 0.95 | CETP (0.37) | CETP | |
| Water SCHEMBL17223739 | 0.95 | CETP (0.37) | CETP | |
| SCHEMBL30373704 | 0.95 | CETP (0.37) | CETP | |
| SCHEMBL31373865 | 0.95 | CETP (0.37) | CETP | |
| Hydrochloric Acid SCHEMBL16553544 | 0.95 | CETP (0.37) | CETP | |
| Methyl Alcohol SCHEMBL27427612 | 0.91 | CETP (0.35) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023153808-A1 | NON-AQUEOUS ELECTROLYTE ADDITIVE FOR SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTE AND SECONDARY BATTERY COMPRISING SAME | 프로지니어 주식회사 | 2023-08-17 | — | — | WO | disclosed |
| CN-109790202-A | Cyclic peptide, affinity chromatography carrier, labeled antibody, antibody drug complex and pharmaceutical preparation | 富士胶片株式会社 | 2019-05-21 | — | — | CN | disclosed |
| CN-109415403-A | Steroids 6.7. beta epoxide compound as chemical intermediate | NZP英国有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-109415404-A | 6,7- α-process for epoxidation and intermediate for steroids 4,6- diene | NZP英国有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-108137651-A | Cyclic peptide, affinity chromatography carrier, labelled antibody, antibody drug compound and pharmaceutical preparation | 富士胶片株式会社 | 2018-06-08 | — | — | CN | disclosed |
| EP-1685092-B1 | ASYMMETRIC REDUCTIVE AMINATION OF KETO ACID DERIVATIVES FOR PRODUCING AMINO ACID DERIVATIVES | TAKASAGO PERFUMERY CO LTD (JP) | 2010-01-13 | — | — | EP | disclosed |
| US-7626034-B2 | Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-12-01 | — | — | US | disclosed |
| US-20070142443-A1 | Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1685092-A2 | ASYMMETRIC REDUCTIVE AMINATION OF KETO ACID DERIVATIVES FOR PRODUCING AMINO ACID DERIVATIVES | Takasago International Corporation (JP) | 2006-08-02 | — | — | EP | disclosed |
| WO-2005028419-A2 | ASYMMETRIC REDUCTIVE AMINATION OF KETO ACID DERIVATIVES FOR PRODUCING AMINO ACID DERIVATIVES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2005-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142443-A1 | Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives | AADAT, BCAT2, BCAT1 | CETP 3737/4885ALDH1A1 326/4885HSD17B10 426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.